IP Library Granted Patent US 9,603,827
Granted Patent B2
US 9,603,827 · App. 14/984,655 · Granted Mar 28, 2017

Method for preventing and/or treating hairy wart disease

Inventors: Keiji Okada (Morioka, JP); Yasushi Sekiyama (Chiyoda, JP)
Assignees: MITSUBISHI-KAGAKU FOODS CORPORATION; INCORPORATED NATIONAL UNIVERSITY IWATE UNIVERSITY
A61K31/26A61K9/0017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,603,827
App. No.
14/984,655
Granted
Mar 28, 2017
Kind
B2
Abstract

Provided is a novel method for preventing and/or treating hairy wart disease which is a hoof and leg disease of ungulates. The method is carried out by administering an isothiocyanic acid ester such as allyl isothiocyanate to a hoof of an ungulate. Examples of ungulates targeted for application of the present invention include cows such as dairy cows as well as sheep, pigs and horses.

Claims (13)

1. A method for treating hairy wart disease by administering a therapeutic composition comprising at least 5% by weight of an isothiocyanic acid ester as an active ingredient to a hoof of an ungulate in need thereof, wherein the isothiocyanic acid ester is a C 2-6 alkenyl isothiocyanate, aryl isothiocyanate, C 1-6 alkyl isothiocyanate, phenyl C 1-6 alkyl isothiocyanate or C 3-6 cycloalkyl isothiocyanate.

2. The method according to claim 1 , wherein the isothiocyanic acid ester is a C 2-6 alkenyl isothiocyanate.

3. The method according to claim 1 , wherein the isothiocyanic acid ester is administered to a hoof of an ungulate after hoof trimming.

4. A therapeutic agent for hairy wart disease, comprising at least 5% by weight of an isothiocyanic acid ester as an active ingredient thereof, wherein the isothiocyanic acid ester is a C 2-6 alkenyl isothiocyanate, aryl isothiocyanate, C 1-6 alkyl isothiocyanate, phenyl C 1-6 alkyl isothiocyanate or C 3-6 cycloalkyl isothiocyanate.

5. The therapeutic agent according to claim 4 , wherein the isothiocyanic acid ester is a C 2-6 alkenyl isothiocyanate.

6. The method according to claim 1 , wherein the therapeutic agent is sprayed, applied or affixed to an affected area of the hoof.

7. The method according to claim 1 , wherein the therapeutic agent is a powdered composition.

8. The method according to claim 1 , wherein the hairy wart disease is digital dermatitis.

9. The method according to claim 1 , wherein the hairy wart disease is caused by a pathogen of the genus Treponema.

10. The therapeutic agent according to claim 4 , which is in the form of a powdered composition.

11. A method for treating hairy wart disease by administering a therapeutic agent comprising at least 5% by weight of an isothiocyanic acid ester as an active ingredient thereof to a hoof of an ungulate in need thereof,

wherein the isothiocyanic acid ester is a C 2-6 alkenyl isothiocyanate, aryl isothiocyanate, C 1-6 alkyl isothiocyanate, phenyl C 1-6 alkyl isothiocyanate or C 3-6 cycloalkyl isothiocyanate, and

the therapeutic agent is sprayed, applied or affixed directly to an affected area.

Assignments (3)
CHANGE OF NAME Recorded May 17, 2021
From: MITSUBISHI-KAGAKU FOODS CORPORATION
To: MITSUBISHI-CHEMICAL FOODS CORPORATION
Reel/Frame 056266/0797 →
MERGER Recorded May 17, 2021
From: MITSUBISHI-CHEMICAL FOODS CORPORATION
To: MITSUBISHI CHEMICAL CORPORATION
Reel/Frame 056266/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2015
From: OKADA, KEIJI; SEKIYAMA, YASUSHI
To: MITSUBISHI-KAGAKU FOODS CORPORATION; INCORPORATED NATIONAL UNIVERSITY IWATE UNIVERSITY
Reel/Frame 037385/0783 →
Continuity (2)
Continuation PCTJP2014067769 · Jul 3, 2014
Related Publication 20160106701A1 · Apr 21, 2016